Contextualising the developability risk of antibodies with lambda light chains using enhanced therapeutic antibody profiling

Abstract Antibodies with lambda light chains (λ-antibodies) are generally considered to be less developable than those with kappa light chains (κ-antibodies). Though this hypothesis has not been formally established, it has led to substantial systematic biases in drug discovery pipelines and thus co...

Full description

Bibliographic Details
Main Authors: Matthew I. J. Raybould, Oliver M. Turnbull, Annabel Suter, Bora Guloglu, Charlotte M. Deane
Format: Article
Language:English
Published: Nature Portfolio 2024-01-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-023-05744-8